The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

What does Trump's decision to leave the WHO mean for public health? And should U.S. companies be intimidated by Chinese drug ...

Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for the 2025 J.P. Morgan ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

As top pharma executives arrive in San Francisco, CA, to attend the J.P. Morgan Healthcare Conference next week, biotech ...

San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...

a $7.5 billion biotech hedge fund, speaking during a STAT event here on the sidelines of the J.P. Morgan Healthcare Conference in San Francisco. Edelman started his fund in 1999. Investing in ...

Take a look back at the biggest stories of the week with Fierce Biotech’s conference's kickoff coverage here and the full lowdown from Day 2 here. Check out all the latest news below ...

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...

As the healthcare and life sciences industry gears up for the highly anticipated JP Morgan Healthcare Conference later this month, stakeholders ...